Positively Sharing

GSK: ViiV Healthcare Reports Superior Efficacy Of Cabotegravir For HIV Prevention In Women

Reading Time: < 1 minute

GlaxoSmithKline plc (GSK, GSK.L) said Monday that its majority-owned specialist HIV company ViiV Healthcare has revealed interim analysis from HPTN 084 study Read More

Exit mobile version